Because "GLP-1" is associated with prescription drug mechanisms, companies in this category often need to be especially careful about how they describe their products to avoid implying drug-like effects
You cannot simply take Akkermansia alone and expect the same results
This can be especially appealing for patients who are nervous about nausea, have a history of medication sensitivity, are close to their goal weight, want help with food noise rather than aggressive weight loss, or prefer a more conservative plan
All other GLP-1s with FDA approval, such as Ozempic and Mounjaro, are approved for the treatment of type 2 diabetes
Ozempic and Tirzepatide (Mounjaro) are primarily approved for type 2 diabetes management, but recent research highlights their potential benefits for non-diabetic individuals, particularly in weight management
Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, et al